Angelo A Manfredi
Overview
Explore the profile of Angelo A Manfredi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
173
Citations
10974
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sciorati C, De Lorenzo R, Lore N, Tresoldi C, Cirillo D, Ciceri F, et al.
Pharmacol Res
. 2022 Dec;
187:106601.
PMID: 36513209
No abstract available.
12.
Maugeri N, Manfredi A
J Thromb Haemost
. 2022 Aug;
20(9):2161-2163.
PMID: 35968795
No abstract available.
13.
De Lorenzo R, Sciorati C, Lore N, Capobianco A, Tresoldi C, Cirillo D, et al.
Sci Rep
. 2022 May;
12(1):7606.
PMID: 35534648
Infectious and inflammatory stimuli elicit the generation of chitinase-3-like protein-1 (CHI3L1), involved in tissue damage, repair and remodeling. We evaluated whether plasma CHI3L1 at disease onset predicts clinical outcome of...
14.
De Lorenzo R, Sciorati C, Ramirez G, Colombo B, Lore N, Capobianco A, et al.
PLoS One
. 2022 Apr;
17(4):e0267235.
PMID: 35468164
Background: Chromogranin A (CgA) and its fragment vasostatin I (VS-I) are secreted in the blood by endocrine/neuroendocrine cells and regulate stress responses. Their involvement in Coronavirus 2019 disease (COVID-19) has...
15.
Maugeri N, De Lorenzo R, Clementi N, Diotti R, Criscuolo E, Godino C, et al.
J Thromb Haemost
. 2021 Oct;
20(2):434-448.
PMID: 34710269
Background: Platelet activation and thrombotic events characterizes COVID-19. Objectives: To characterize platelet activation and determine if SARS-CoV-2 induces platelet activation. Patients/methods: We investigated platelet activation in 119 COVID-19 patients at...
16.
Lore N, De Lorenzo R, Rancoita P, Cugnata F, Agresti A, Benedetti F, et al.
Mol Med
. 2021 Oct;
27(1):129.
PMID: 34663207
Background: Host inflammation contributes to determine whether SARS-CoV-2 infection causes mild or life-threatening disease. Tools are needed for early risk assessment. Methods: We studied in 111 COVID-19 patients prospectively followed...
17.
Di Filippo L, De Lorenzo R, Sciorati C, Capobianco A, Lore N, Giustina A, et al.
Diabetes Metab
. 2021 Aug;
47(6):101268.
PMID: 34333093
Aim: Obesity is a risk factor for COVID-19, but the underlying mechanisms are unclear. We investigated the role of adiponectin (an anti-inflammatory adipokine), leptin (a pro-inflammatory adipokine) and their ratio...
18.
Manfredi A, Ramirez G, Godino C, Capobianco A, Monno A, Franchini S, et al.
Arthritis Rheumatol
. 2021 Jul;
74(2):318-328.
PMID: 34279048
Objective: It is unclear why activated platelets and platelet-derived microparticles (MPs) accumulate in the blood of patients with systemic sclerosis (SSc). This study was undertaken to investigate whether defective phagocytosis...
19.
Ackermann M, Anders H, Bilyy R, Bowlin G, Daniel C, De Lorenzo R, et al.
Cell Death Differ
. 2021 May;
28(11):3125-3139.
PMID: 34031543
SARS-CoV-2 infection poses a major threat to the lungs and multiple other organs, occasionally causing death. Until effective vaccines are developed to curb the pandemic, it is paramount to define...
20.
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients
De Lorenzo R, Lore N, Finardi A, Mandelli A, Cirillo D, Tresoldi C, et al.
J Neurol
. 2021 May;
268(12):4436-4442.
PMID: 33973106
Background And Aims: Patients infected with SARS-CoV-2 range from asymptomatic, to mild, moderate or severe disease evolution including fatal outcome. Thus, early predictors of clinical outcome are highly needed. We...